Helsinn is a privately-owned pharmaceutical group with headquarters in Lugano, Switzerland, and operating subsidiaries in Ireland, USA and China. Founded in 1976, the company has become known worldwide for its unique business model focused on the licensing of innovative pharmaceuticals, medical devices and nutritional supplement products in therapeutic niche areas. The active pharmaceutical ingredients and the finished dosage forms are manufactured at Helsinn’s cGMP facilities in Switzerland and Ireland, and supplied worldwide to its customers.
Today Helsinn is committed to advancing quality patient care through the development and commercialization of cancer supportive care treatments to benefit both patients and caregivers. Helsinn focuses R&D investments and resources on enhancing cancer supportive care, a still underserved yet important therapeutic area.
A modern Group focused on growth and development but also tied to tradition and on the values of a family business: in Helsinn more than 500 employees work not only for the health of the patient, but overall for the quality of life of the person.
Helsinn Birex offers interesting and challenging careers in a team based workplace with modern facilities and opportunities for advancement.
The National Workplace Wellbeing Day Award 2017
Ireland is a global center for pharmaceuticals manufacturing and supply for the top pharmaceutical companies worldwide with an excellent reputation for GMP compliance.
In 2011 investments were made to increase the analytical testing capacity on the site. Helsinn has invested more than CHF50 million in Dublin and in dedicated capacity at the sites of its strategic contract manufacturing partners to guarantee all elements of the supply chain for development and commercial products.
Recent awards :
Helsinn earned the Global CEO Cancer Gold Standard™ Accreditation, an important validation of our commitment to reducing the risk of cancer amongst our employees.
Awarded Bronze in the national Healthy Eating at Work Scheme
In 2016 Helsinn Birex won the RoSPA (Royal Society of the Prevention of Accidents) Gold International award, the highest award possible for a new entrant.
Please enter your email address
The EU-QPPV is responsible for the management and maintenance of the Helsinn Group pharmacovigilance system. He/she has to oversight the safety profiles and any emerging safety concern related to the Helsinn medicinal products authorized in the EU.